Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Respiration; International Review of Thoracic Diseases
|
May 13, 2003
Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer
K M Beeh, J Beier, M Ernst, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 12, 2003
A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5
K M Beeh, J Beier, O Kornmann, et al.
Pulmonary Pharmacology & Therapeutics
|
May 26, 2009
Bronchodilator effects of indacaterol and formoterol in patients with COPD
J Beier, K-M Beeh, L Brookman, et al.
The European Respiratory Journal
|
July 11, 2002
Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis
K M Beeh, J Beier, I C Haas, et al.
Respiration; International Review of Thoracic Diseases
|
February 14, 2003
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease
O Kornmann, K M Beeh, J Beier, et al.
The European Respiratory Journal
|
January 26, 2007
Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma
K M Beeh, E Derom, F Kanniess, et al.
Pneumologie (Stuttgart, Germany)
|
June 9, 2006
[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]
K M Beeh, J Beier, R Buhl, et al.
Pneumologie (Stuttgart, Germany)
|
September 7, 2002
[Onset of action of formoterol in patients with moderate to severe, partially reversible airflow obstruction assessed by bodyplethysmography]
J Beier, K M Beeh, K Tröger, et al.
International Journal of Cancer
|
April 17, 2001
c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis
P Micke, J G Hengstler, R Ros, et al.
Pulmonary Pharmacology & Therapeutics
|
December 8, 2007
Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease
L Grönke, K M Beeh, R Cameron, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Respiration; International Review of Thoracic Diseases
|
May 13, 2003
Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer
K M Beeh, J Beier, M Ernst, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 12, 2003
A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5
K M Beeh, J Beier, O Kornmann, et al.
Pulmonary Pharmacology & Therapeutics
|
May 26, 2009
Bronchodilator effects of indacaterol and formoterol in patients with COPD
J Beier, K-M Beeh, L Brookman, et al.
The European Respiratory Journal
|
July 11, 2002
Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis
K M Beeh, J Beier, I C Haas, et al.
Respiration; International Review of Thoracic Diseases
|
February 14, 2003
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease
O Kornmann, K M Beeh, J Beier, et al.
The European Respiratory Journal
|
January 26, 2007
Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma
K M Beeh, E Derom, F Kanniess, et al.
Pneumologie (Stuttgart, Germany)
|
June 9, 2006
[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]
K M Beeh, J Beier, R Buhl, et al.
Pneumologie (Stuttgart, Germany)
|
September 7, 2002
[Onset of action of formoterol in patients with moderate to severe, partially reversible airflow obstruction assessed by bodyplethysmography]
J Beier, K M Beeh, K Tröger, et al.
International Journal of Cancer
|
April 17, 2001
c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis
P Micke, J G Hengstler, R Ros, et al.
Pulmonary Pharmacology & Therapeutics
|
December 8, 2007
Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease
L Grönke, K M Beeh, R Cameron, et al.
Page
of 4